Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

362
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
362
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

250
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
250
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

568
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
568
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

172
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
172
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

189
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
189

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer.

Translational cancer research·2026
Same author

Ferroptosis Signature Correlates with Ovarian Cancer Prognosis and Chemotherapy Response.

International journal of general medicine·2026
Same author

Integrated network pharmacology, gut microbiome, and metabolomics analyses reveal the protective mechanism of Guizhi Gegen decoction against influenza.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

EPHB2 drives EMT-linked vasculogenic mimicry and cervical cancer progression via an ERK-ETV4 transcriptional program.

Journal of translational medicine·2026
Same author

Curcumin modulates the function of SPP1+ macrophages via NF-κB signaling to alleviate endometriosis.

International immunopharmacology·2026
Same author

Comparative analysis of tissue-specific anticancer peptide prediction models: ACP-Boost framework.

Frontiers in molecular biosciences·2026

Related Experiment Video

Updated: Aug 25, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

888

Andrographolide, a natural anti-inflammatory agent: An Update.

Xiaohong Li1,2, Weichen Yuan3, Jibiao Wu4

  • 1First Clinical School of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Frontiers in Pharmacology
|October 14, 2022
PubMed
Summary

Andrographolide, derived from Andrographis paniculata, shows significant anti-inflammatory effects across various diseases. This review highlights its mechanisms, targets, and potential as a therapeutic agent.

Keywords:
andrographolideanti-inflammationimmunomodulationinflammatory diseasesreview

More Related Videos

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.6K
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.1K

Related Experiment Videos

Last Updated: Aug 25, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

888
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.6K
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.1K

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Immunology

Background:

  • Botanicals are recognized for potent anti-inflammatory properties.
  • Andrographis paniculata is a globally utilized medicinal plant.
  • Andrographolide is the primary bioactive compound in Andrographis paniculata.

Purpose of the Study:

  • To review the applications of andrographolide in treating inflammatory conditions.
  • To elucidate the anti-inflammatory mechanisms and molecular targets of andrographolide.
  • To assess the safety and future clinical potential of andrographolide.

Main Methods:

  • Literature review of studies on andrographolide's anti-inflammatory effects.
  • Analysis of research on its action in various systemic diseases.
  • Evaluation of toxicity data and safety profiles.

Main Results:

  • Andrographolide demonstrates efficacy in inflammatory diseases of the respiratory, digestive, immune, nervous, cardiovascular, skeletal, and tumor systems.
  • It modulates numerous inflammation-related signaling pathways.
  • Research indicates a favorable safety profile for andrographolide.

Conclusions:

  • Andrographolide is a promising natural compound for managing diverse inflammatory diseases.
  • Its broad-spectrum anti-inflammatory activity and safety profile support further clinical investigation.
  • Future research should focus on optimizing andrographolide's therapeutic applications.